Finorify

ABT

Abbott Laboratories

$101.29+0.22%

Price

ABT daily closing price
Market cap
$176.5 billion
P/E (TTM)
28.37
EV/EBITDA
18.34
52W range
$82.56 – $136.62
Div yield
2.41%
Volume
7.2M
Sector
Healthcare

Abbott Laboratories (ABT) last closed at $101.29, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for ABT, covered for search and blurred for visitors.

Performance

  • 1D-1.89%
  • 5D-2.39%
  • 1M-3.07%
  • 3M-0.24%
  • 6M+9.61%
  • 1Y-22.39%
  • 5Y-14.09%

Financials

ABT revenueQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Over the latest four reported periods ending March 31, 2026, Abbott Laboratories reported revenue of $45.13 billion.

The prior window totaled $42.34 billion, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $9.46 billion.

Free cash flow in the latest window was $7.38 billion.

These amounts are taken from Abbott Laboratories's SEC filings and are a snapshot as of March 31, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 2.1% (19 of 100). Leverage: D/E 0.57× (77 of 100). Cash generation: FCF margin 16.3% (33 of 100). Net margin: 9.6% (24 of 100). Liquidity: Current 1.39× (69 of 100).

Cash Flow

ABT free cash flowQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Margins

ABT operating margin

Valuation

P/E (TTM)
28.37
P/S (TTM)
3.91
EV/EBITDA
18.34

Insights

Finorify has not written notes for ABT in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open ABT in Finorify